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licenseAlternative treatment for hot flashesHot flashes (also called hot flushes) are one of the most
common, bothersome, and distressing symptoms that women
undergo during menopause. These flashes are a vasomotor
symptom that significantly deteriorates a woman's quality of
life because they can cause chills, night sweats, palpitation,
as well as sleep disturbance and insomnia, and may persist
for years.1,2 One report showed that in excess of half of
women living in the USA experienced hot flashes during their
menopausal transition, and one-third reported symptoms
persisting more than 10 years after menopause,3 suggesting
that many postmenopausal women need help to minimize the
symptom impact of their hot flashes. Clinical practices are
increasingly confronted with a variety of medical challenges
that directly impact a woman's natural menopausal transition.
Such challenges include oophorectomy due to various dis-
eases such as endometrial cancer,4e6 breast cancer treatment
by endocrine therapies (e.g., aromatase inhibitors,
gonadotropin-releasing hormone agonist, and tamoxifen),7,8
endocrine manipulations, and chemotherapy with a resultant
premature ovarian failure9; all of these treatments are
increasingly found in clinical practice because the incidence
and/or prevalence of breast cancer has expanded significantly
worldwide.10,11
Endocrine manipulations are especially important for the
management of breast cancer in young (premenopausal)
women. More than two-thirds of breast cancer patients
undergoing the various kinds of endocrine manipulations will
have their treatments complicated with differing degrees of
vasomotor symptoms, including hot flashes, a troublesome
side effect that impacts patient adherence to treatment. When
patients fail to adhere to endocrine therapy, this subsequently
contributes to worse prognosis for these premenopausal
patients.1 The general consensus is that adequate relief of
vasomotor symptoms, such as hot flashes, is of paramount
importance.
There is no doubt that hormonal therapy, especially estro-
gen therapy, is the most effective therapy for all menopause-
related vasomotor symptoms, including hot flashes. How-
ever, because of the strong evidence of risky hormones,
especially the regimen of combined estrogen and progester-
one,12,13 the use of hormonal therapy is not appropriate as
first-line therapy. In fact, only a small fraction of womenx.doi.org/10.1016/j.jcma.2016.02.001
901/Copyright © 2016, the Chinese Medical Association. Published by El
(http://creativecommons.org/licenses/by-nc-nd/4.0/).complicated with hot flashes will benefit from hormonal
therapy. Hence, it has been established that the demand for
using alternative and/or complementary medicine/therapy,
such as nonhormonal pharmacological therapies [e.g., anti-
depressants (selective serotonin reuptake inhib-
itorsdparoxetine, citalopram, and venlafaxine), antiepileptics
(gabapentin), and antihypertensives (clonidine)], physical and
behavioral therapies [e.g., yoga/exercise/massage, relaxation,
and cognitive behavioral modifications (wearing light clothes,
lowering room temperature using air conditioners, and
avoiding hot or spicy food intake)], and acupuncture, as well
as natural health products/herb medication [e.g., phytoes-
trogen (soy isoflavones, red clover isoflavones, genistein, etc.),
black cohosh, licorice, chaste tree, dong quai, flaxseed, gin-
seng, primrose oil, lavender aromatherapy, and vitamin E] has
increased, and these are important for those women who need
relief from their hot flashes.1,2,14 In spite of this increase, the
evidence is not sufficient to confirm whether alternative or
complementary therapy is effective and reliable. Furthermore,
some patients were limited to their side effects. For example,
antidepressants are reported to have modest effects on hot
flashes.1
The study by Kazemzadeh et al14 in this issue of the
Journal of the Chinese Medical Association, entitled The effect
of lavender aromatherapy on menopause hot flushing: A cross-
over randomized clinical trial addressed the above question.
The study enrolled 100 healthy women complicating with hot
flashes, and divided them into two groups with 50 individuals
in each group. At the end of treatment (12 weeks), the authors
found that those women treated with lavender aromatherapy
had a significant decrease in the number of hot flash episodes
compared to those without treatment (10.6 vs. 19.7,
p < 0.001). In addition, the severity of hot flashes was also
significantly reduced in women with lavender aromatherapy
compared with that in women without (1.13 vs. 2.11,
p ¼ 0.002). Based on the obvious and significant positive
impact on menopausal hot flashes in women who were treated
with lavender aromatherapy, the authors concluded that this
simple, noninvasive, safe, and effective therapy could be
suggested for postmenopausal women with hot flashes.14
Consequently, in the current issue,14 although further con-
firmation is still required, there has been widespread interest insevier Taiwan LLC. This is an open access article under the CC BY-NC-ND
469Editorial / Journal of the Chinese Medical Association 79 (2016) 468e469identifying nonpharmacologic therapies that are not only
effective, but safe and well-tolerated.
In fact, there is a recent trend for some women with hot
flashes to seek symptom relief by using the alternative and/or
complementary therapy because of a measure of cancer phobia
and/or evidence of the increasing adverse events after the use
of conventional hormonal therapy. This may occur even
though researchers cannot provide enough evidence to show
the similar therapeutic effect of alternative and/or comple-
mentary therapy compared with hormonal therapy. Before
obtaining the solid data to support the efficacy of alternative
and/or complementary therapy on symptomatic post-
menopausal women, more studies are needed. To reach this
goal, a well-designed, prospective, randomized trial is espe-
cially important.
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